STERIS (STE)
(Delayed Data from NYSE)
$228.77 USD
+4.48 (2.00%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $228.84 +0.07 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Company Summary
Ohio-headquartered STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. The legacy company was originally known as STERIS Corporation. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name – STERIS plc.
Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers in more than 60 countries across the globe. The majority of STERIS’ revenues is derived from the healthcare and pharmaceutical industries. STERIS divested the Synergy Health Healthcare Consumable Solutions (&...
Company Summary
Ohio-headquartered STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. The legacy company was originally known as STERIS Corporation. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name – STERIS plc.
Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers in more than 60 countries across the globe. The majority of STERIS’ revenues is derived from the healthcare and pharmaceutical industries. STERIS divested the Synergy Health Healthcare Consumable Solutions ("HCS") business in fiscal 2018 to Vernacare, a manufacturer of healthcare infection prevention solutions.
During fiscal 2022, the company’s acquisition of Cantel Medical LLC added a new dental business focused on infection prevention protocols and processes. On Apr 11, 2024, STERIS announced a definitive agreement to divest the Dental segment for a transaction amount of $787.5 million. The division’s net assets and operations have since been reclassified to discontinued operations.
Presently, the company operates through three segments — Healthcare, Applied Sterilization Technologies (AST)and Life Sciences.
Healthcare (70.3% of total revenues in fiscal 2024, up 17.1% from fiscal 2023): Effective Apr 1, 2020, the company’s legacy Healthcare Products and Healthcare Specialty Services arms were combined and reported as Healthcare. This biggest segment of STERIS includes Healthcare Products part of the business which offers infection prevention and procedural solutions for global healthcare providers. The Healthcare Specialty Services part comprises specialty services including hospital sterilization services, instrument and scope repairs and linen management.
AST (18.6%, up 7.2%):This segment offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Life Sciences (11.1%, up 6.5%): This segment offers capital equipment and consumable products and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities.
General Information
STERIS plc
70 Sir John Rogerson`s Quay
Dublin, L2 D02 R296
Phone: 353-1232-2000
Fax: 440-639-4457
Email: julie_winter@steris.com
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | March |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 8/6/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 2.03 |
Current Year EPS Consensus Estimate | 9.25 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 8/6/2024 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 224.29 |
52 Week High | 254.00 |
52 Week Low | 195.47 |
Beta | 0.83 |
20 Day Moving Average | 416,164.81 |
Target Price Consensus | 243.33 |
4 Week | 2.83 |
12 Week | 10.00 |
YTD | 2.02 |
4 Week | 2.07 |
12 Week | 1.91 |
YTD | -11.60 |
Shares Outstanding (millions) | 98.85 |
Market Capitalization (millions) | 22,171.79 |
Short Ratio | NA |
Last Split Date | 8/25/1998 |
Dividend Yield | 0.93% |
Annual Dividend | $2.08 |
Payout Ratio | 0.24 |
Change in Payout Ratio | -0.01 |
Last Dividend Payout / Amount | 6/12/2024 / $0.52 |
Fundamental Ratios
P/E (F1) | 24.26 |
Trailing 12 Months | 25.90 |
PEG Ratio | NA |
vs. Previous Year | 4.78% |
vs. Previous Quarter | 8.56% |
vs. Previous Year | 2.49% |
vs. Previous Quarter | 1.70% |
Price/Book | 3.51 |
Price/Cash Flow | 15.98 |
Price / Sales | 4.07 |
6/30/24 | NA |
3/31/24 | 13.73 |
12/31/23 | 13.67 |
6/30/24 | NA |
3/31/24 | 7.74 |
12/31/23 | 7.68 |
6/30/24 | NA |
3/31/24 | 3.08 |
12/31/23 | 2.43 |
6/30/24 | NA |
3/31/24 | 2.36 |
12/31/23 | 1.49 |
6/30/24 | NA |
3/31/24 | 15.84 |
12/31/23 | 15.73 |
6/30/24 | NA |
3/31/24 | 6.95 |
12/31/23 | 10.48 |
6/30/24 | NA |
3/31/24 | 13.68 |
12/31/23 | 22.29 |
6/30/24 | NA |
3/31/24 | 63.91 |
12/31/23 | 65.06 |
6/30/24 | NA |
3/31/24 | 3.74 |
12/31/23 | 3.68 |
6/30/24 | NA |
3/31/24 | 0.49 |
12/31/23 | 0.50 |
6/30/24 | NA |
3/31/24 | 33.07 |
12/31/23 | 33.45 |